LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 2 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 2. - Dataset (ID:20310)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 42.45 | 17.25 | 4324 | 3504 | 1.2340 | 1.0556 | MN20160310_N02 | I21 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 44.42 | 17.25 | 6 | 3895 | 0.0015 | -0.1264 | MN20160310_N02 | D17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 44.42 | 17.25 | 3831 | 3895 | 0.9834 | 0.9957 | MN20160310_N02 | D17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 44.42 | 17.25 | 19 | 3895 | 0.0049 | 0.0124 | MN20160310_N02 | I21 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 44.42 | 17.25 | 4773 | 3895 | 1.2252 | 1.0526 | MN20160310_N02 | I21 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 46.39 | 17.25 | 3 | 4141 | 0.0007 | -0.1985 | MN20160310_N02 | D17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 46.39 | 17.25 | 4148 | 4141 | 1.0016 | 1.0004 | MN20160310_N02 | D17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 46.39 | 17.25 | 20 | 4141 | 0.0048 | 0.0189 | MN20160310_N02 | I21 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 46.39 | 17.25 | 5263 | 4141 | 1.2708 | 1.0615 | MN20160310_N02 | I21 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 48.36 | 17.25 | 3 | 4390 | 0.0007 | -0.1966 | MN20160310_N02 | D17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 48.36 | 17.25 | 4459 | 4390 | 1.0156 | 1.0039 | MN20160310_N02 | D17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 48.36 | 17.25 | 17 | 4390 | 0.0039 | -0.0018 | MN20160310_N02 | I21 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 48.36 | 17.25 | 5623 | 4390 | 1.2808 | 1.0629 | MN20160310_N02 | I21 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 50.33 | 17.25 | 5 | 4651 | 0.0011 | -0.1422 | MN20160310_N02 | D17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 50.33 | 17.25 | 4892 | 4651 | 1.0518 | 1.0125 | MN20160310_N02 | D17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 50.33 | 17.25 | 16 | 4651 | 0.0034 | -0.0093 | MN20160310_N02 | I21 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 50.33 | 17.25 | 5997 | 4651 | 1.2894 | 1.0639 | MN20160310_N02 | I21 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 52.30 | 17.25 | 4 | 4798 | 0.0008 | -0.1647 | MN20160310_N02 | D17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 52.30 | 17.25 | 5235 | 4798 | 1.0909 | 1.0216 | MN20160310_N02 | D17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 52.30 | 17.25 | 24 | 4798 | 0.0050 | 0.0415 | MN20160310_N02 | I21 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 52.30 | 17.25 | 6407 | 4798 | 1.3352 | 1.0725 | MN20160310_N02 | I21 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 54.27 | 17.25 | 9 | 4884 | 0.0018 | -0.0768 | MN20160310_N02 | D17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 54.27 | 17.25 | 5833 | 4884 | 1.1943 | 1.0441 | MN20160310_N02 | D17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 54.27 | 17.25 | 17 | 4884 | 0.0035 | -0.0018 | MN20160310_N02 | I21 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 54.27 | 17.25 | 6838 | 4884 | 1.4001 | 1.0844 | MN20160310_N02 | I21 |